Depressive disorders place a significant economic burden worldwide, with projections indicating they will rank second only to ischemic heart disease in global burden by 2020.
Depressive disorders impose a massive global economic and societal burden, projected to be second only to ischemic heart disease by 2020.
Depressive disorders place a significant economic burden on patients, families, caregivers, employers and payers worldwide. The costs of depression are similar in magnitude to, although differently distributed, the costs of cancer, AIDS, and coronary heart disease. Currently, projections indicate that the global burden of depression alone, measured in terms of disability-adjusted life years, will rank second only to ischemic heart disease in the year 2020. Depression is often characterized by repeated relapse or recurrent episodes. The significant disease chronicity that is associated with depression magnifies its long-term societal impact and economic burden.
Rosenbaum et al. (Fri,) conducted a review in Depressive disorders. Depressive disorders was evaluated on Economic burden and disability-adjusted life years. Depressive disorders place a significant economic burden worldwide, with projections indicating they will rank second only to ischemic heart disease in global burden by 2020.